Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.

Following induction chemotherapy, moderate-dose proton therapy can potentially reduce toxicity in the brain and skull base region without compromising disease control. However, further follow-up is needed to fully characterize and evaluate any reduction in long-term complications.